Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Infectious Diseases

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/507306PMID 16960777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AIDS Res Hum Retroviruses

  2006cited by this paper
• Measurement of Intracellular Didanosine and Tenofovir Phosphorylated Metabolites and Possible Interaction of the Two Drugs in Human Immunodeficiency Virus-Infected Patients

  2005cited by this paper
• Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.

  2005cited by this paper
• Promote HIV Chemoprophylaxis Research, Don't Prevent It

  2005cited by this paper
• Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

  2005cited by this paper
• Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges

  2005cited by this paper
• Brief but efficient: acute HIV infection and the sexual transmission of HIV.

  2004cited by this paper
• Highly Uneven Distribution of Tenofovir-Selected Simian Immunodeficiency Virus in Different Anatomical Sites of Rhesus Macaques

  2004cited by this paper
• Pre-exposure chemoprophylaxis for HIV: It is time

  2004cited by this paper
• A Period of Transient Viremia and Occult Infection Precedes Persistent Viremia and Antiviral Immune Responses during Multiple Low-Dose Intravaginal Simian Immunodeficiency Virus Inoculations

  2004influential reference
• Repeated Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge Results in the Same Viral and Immunological Kinetics as High-Dose Challenge: a Model for the Evaluation of Vaccine Efficacy in Nonhuman Primates

  2004cited by this paper
• Tenofovir Disoproxil Fumarate

  2004cited by this paper
• Pre-Exposure Chemoprophylaxis (PREP) as an HIV Prevention Strategy

  2003cited by this paper
• Recent observations on HIV type-1 infection in the genital tract of men and women.

  2003cited by this paper
• Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatography.

  2003cited by this paper
• Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

  2001influential reference
• Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

  2001cited by this paper
• Chronic immune stimulation accelerates SIV‐induced disease progression

  2001cited by this paper
• Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)

  2000cited by this paper
• Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV/HIV chimera.

  2000cited by this paper
• Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.

  1999cited by this paper
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

  1999cited by this paper
• Safety, Pharmacokinetics, and Antiretroviral Activity of Intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a Novel Anti-Human Immunodeficiency Virus (HIV) Therapy, in HIV-Infected Adults

  1998cited by this paper
• Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection

  1998cited by this paper
• The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.

  1998cited by this paper
• Administration of 9-[2-(Phosphonomethoxy)propyl] adenine (PMPA) for Prevention of Perinatal Simian Immunodeficiency Virus Infection in Rhesus Macaques

  1998cited by this paper
• A Case-Control Study of HIV Seroconversion in Health Care Workers After Percutaneous Exposure

  1998cited by this paper
• Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment

  1998cited by this paper
• A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

  1997cited by this paper
• Probabilities of sexual HIV‐1 transmission

  1996cited by this paper
• A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys

  1996cited by this paper
• Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine

  1995cited by this paper
• Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction.

  1994cited by this paper
• Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

  1994cited by this paper
• Combining dependent tests with incomplete repeated measurements

  1985cited by this paper
• Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate Observations

  1984cited by this paper

• The Use of Nonhuman Primate Models for Advancing HIV PrEP

  2025cites this paper
• Preclinical evaluation of long-acting cabotegravir and rilpivirine for HIV post-exposure prophylaxis in a macaque model

  2025cites this paper
• Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection

  2024cites this paper
• Defining blood hematology reference values in female pig-tailed macaques (Macaca nemestrina) using the Isolation Forest algorithm

  2024cites this paper
• Federal Funding For Discovery And Development Of Costly HIV Drugs Was Far More Than Previously Estimated.

  2023cites this paper
• Physico-chemistry and Cytotoxicity of Tenofovir-Loaded Acid Phosphatase-Responsive Chitosan Nanoparticles

  2023cites this paper
• Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates

  2023cites this paper
• The predictive value of macaque models of preexposure prophylaxis for HIV prevention

  2022cites this paper
• Ultra-long-acting refillable nanofluidic implant confers full protection against SHIV infection in non-human primates

  2022cites this paper
• Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from simian HIV acquisition by long-acting cabotegravir in macaques

  2021cites this paper
• Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus

  2021cites this paper
• Proinflammatory oscillations over the menstrual cycle drives bystander CD4 T cell recruitment and SHIV susceptibility from vaginal challenge

  2021influential citation
• Cabotegravir long-acting protects macaques against repeated penile SHIV exposures

  2020cites this paper
• Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies

  2020cites this paper
• Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

  2020cites this paper
• Use of the guinea pig model of genital herpes to evaluate vaccines and antivirals: review.

  2020cites this paper
• Cabotegravir long-acting protects macaques against repeated penile SHIV exposures.

  2020cites this paper
• Prevention of HIV Infection

  2020cites this paper
• The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques

  2020cites this paper
• Pre-exposure prophylaxis as a prevention strategy for HIV seroconversion in the men who have sex with men population with comparison of its effectiveness in other at-risk groups

  2020cites this paper
• Training rhesus macaques to take daily oral antiretroviral therapy for preclinical evaluation of HIV prevention and treatment strategies

  2019cites this paper
• Analytical treatment interruption after short-term anti-retroviral therapy in a postnatally SHIV infected infant rhesus macaque model

  2019cites this paper
• Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model

  2019cites this paper
• Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV

  2018cites this paper
• Results from the post-exposure prophylaxis pilot program (P-QUAD) demonstration project in Los Angeles County

  2018cites this paper
• Engineering of Human Acid Phosphatase Enzyme Sensitive Nanomedicine for HIV/AIDS Prevention by Topical Route

  2018influential citation
• Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa

  2018cites this paper
• Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice

  2018cites this paper
• Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria.

  2018cites this paper
• HIV Pre-Exposure Prophylaxis: Efficacy and Safety of Approved Therapeutic Regimens and Promising Drugs

  2018cites this paper
• Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens

  2017cites this paper
• Repeated administration of high‐dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings

  2017cites this paper
• HIV-1 Drug Resistance in Pre-exposure Prophylaxis Trials

  2017cites this paper
• On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection

  2017influential citation
• Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.

  2017cites this paper
• Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice

  2017cites this paper
• HIV prophylaxis : an essential role for T cells and adjuvants in recombinant mucosal Lactobacillus acidophilus vaccines

  2017cites this paper
• Efficacy of HIV Pre Exposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies

  2017cites this paper
• Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention

  2016cites this paper
• PrEP: A Review for Mental Health Professionals

  2016cites this paper
• Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance.

  2016cites this paper
• Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports

  2016cites this paper
• Pre-exposure prophylaxis: Primary prevention of HIV in at-risk populations

  2016cites this paper
• Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs

  2016cites this paper
• Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?

  2016cites this paper
• Where next with preexposure prophylaxis?

  2016cites this paper
• Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures

  2016cites this paper
• Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses

  2015cites this paper
• Cabotegravir long-acting for HIV-1 prevention

  2015cites this paper
• The Role of Sociodemographic Characteristics and Antiretroviral Prophylaxis on Risky Sexual Behavior Among Men who Have Sex with Men

  2015cites this paper
• Surrogates of protection in repeated low‐dose challenge experiments

  2015cites this paper
• A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge

  2015cites this paper
• Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in Delivery

  2015cites this paper
• Antiretrovirals for Primary HIV Prevention: the Current Status of Pre- and Post-exposure Prophylaxis

  2015cites this paper
• Andrews 1..9

  2015cites this paper
• The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs

  2015cites this paper
• Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.

  2014cites this paper
• Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaques

  2014cites this paper
• Pre-Exposure Prophylaxis for the Prevention of HIV Infection in High Risk Populations: A Meta-Analysis of Randomized Controlled Trials

  2014cites this paper
• Pre-Exposure Prophylaxis for HIV: Linking Antiretroviral Pharmacokinetics and Pharmacodynamics to Identify Optimal Dosing Strategies

  2014cites this paper
• Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection

  2014cites this paper
• Vaginal microbicides and their delivery platforms

  2014cites this paper
• Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors

  2014cites this paper
• Development and optimization of a non‐enzymatic method of leukocyte isolation from macaque tissues

  2014cites this paper
• Non‐Human Primate Models of Hormonal Contraception and HIV

  2014cites this paper
• Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis.

  2014cites this paper
• Development of a rectal sexually transmitted infection – HIV coinfection model utilizing Chlamydia trachomatis and SHIVSF162p3

  2014cites this paper
• Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.

  2014cites this paper
• HIV-1 Drug Resistance in Preexposure Prophylaxis Trials

  2014cites this paper
• The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.

  2014cites this paper
• Integrase Inhibitors Postexposure Protection of Macaques from Vaginal SHIV Infection by

  2014cites this paper
• HIV Pre-Exposure Prophylaxis Interest among Female Sex Workers in Guangxi, China

  2014cites this paper
• Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus

  2014cites this paper
• Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques

  2014cites this paper
• A Polyvalent Clade B Virus-Like Particle HIV Vaccine Combined with Partially Protective Oral Preexposure Prophylaxis Prevents Simian–Human Immunodeficiency Virus Infection in Macaques and Primes for Virus-Amplified Immunity

  2014cites this paper
• Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.

  2014cites this paper
• PAS‐positive extracellular deposits within germinal centers of hyperplastic follicles during SIV infection in a rhesus macaque

  2014cites this paper
• [Microbicides for preventing sexually transmitted infections: Current status and strategies for preclinical evaluation of new candidates].

  2014cites this paper
• Microbicides for the Prevention of HIV

  2014cites this paper
• Susceptibility to Repeated, Low-Dose, Rectal SHIVSF162P3 Challenge Is Independent of TRIM5 Genotype in Rhesus Macaques

  2013cites this paper
• Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

  2013cites this paper
• Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge

  2013cites this paper
• Use of Antiretrovirals for HIV Prevention: What Do We Know and What Don’t We Know?

  2013cites this paper
• Tenofovir-based HIV pre-exposure prophylaxis

  2013cites this paper
• From modeling to morals: imagining the future of HIV PREP in Lesotho.

  2013cites this paper
• Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.

  2013influential citation
• Lack of Prophylactic Efficacy of Oral Maraviroc in Macaques despite High Drug Concentrations in Rectal Tissues

  2013cites this paper
• Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States

  2013cites this paper
• Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis

  2013cites this paper
• Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

  2013cites this paper
• SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans

  2013cites this paper
• Preexposure Prophylaxis for HIV Prevention: Where Have We Been and Where Are We Going?

  2013cites this paper
• Animal models in virus research: their utility and limitations

  2013cites this paper
• Reduced In fl ammation and CD 4 Loss in Acute SHIV Infection During Oral Pre-Exposure Prophylaxis

  2012cites this paper
• Animal models for microbicide studies.

  2012cites this paper
• The Use of Nonhuman Primate Models of HIV Infection for the Evaluation of Antiviral Strategies

  2012cites this paper
• Animal models of HIV transmission through breastfeeding and pediatric HIV infection.

  2012cites this paper
• Animal models of antiretroviral prophylaxis for HIV prevention

  2012cites this paper
• The use of preexposure treatments for HIV prophylaxis

  2012cites this paper
• Causal Inference and Principal Stratification: Competing Risks, Bounds, and Surrogates

  2012cites this paper